Review
Medicine, General & Internal
Cristina M. Pedrero-Prieto, Javier Frontinan-Rubio, Francisco J. Alcain, Mario Duran-Prado, Juan R. Peinado, Yoana Rabanal-Ruiz
Summary: CSF is considered the best target for biomarker discovery in neurodegenerative diseases due to its deep irrigation of the brain and ease of sample extraction. Discoveries of new proteins in CSF have identified important biomarkers related to AD, and deeper analysis of data from multiple proteomic studies may reveal disrupted components or metabolic pathways in AD.
Review
Clinical Neurology
William T. Hu, Ashima Nayyar, Milota Kaluzova
Summary: Clinical prediction of underlying pathologic substrates in Alzheimer's disease dementia and related dementia syndromes has limited accuracy. Etiologic biomarkers, including CSF levels of AD proteins and cerebral amyloid PET imaging, have improved disease-modifying clinical trials in AD, but their integration into medical practice has been slow. This review discusses the expectations and future applicability of AD/ADRD biomarkers, proposes study designs and performance thresholds, and emphasizes the importance of equity, access, and reliability in biomarker research.
Article
Neurosciences
Soyeon Kim, Kiwon Kim, Kwangsik Nho, Woojae Myung, Hong-Hee Won
Summary: The study found a causal association between CSF biomarkers and the risk of LOAD, suggesting that the etiology of LOAD involves pathways of A beta and tau proteins. Further MR studies using large-scale data are needed to elucidate the pathophysiology of LOAD.
JOURNAL OF ALZHEIMERS DISEASE
(2021)
Article
Clinical Neurology
Janina Krell-Roesch, Martin Rakusa, Jeremy A. Syrjanen, Argonde C. van Harten, Val J. Lowe, Clifford R. Jack, Walter K. Kremers, David S. Knopman, Gorazd B. Stokin, Ronald C. Petersen, Maria Vassilaki, Yonas E. Geda
Summary: This study examined the association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms in older non-demented adults. The results showed that lower CSF Aβ42 and higher t-tau/Aβ42 and p-tau/Aβ42 ratios were associated with depression, anxiety, and other NPS.
ALZHEIMERS & DEMENTIA
(2023)
Article
Neurosciences
Carmen Lage, Andrea Gonzalez-Suarez, Maria Puerto Alcalde-Hierro, Maria Isabel Sampedro-Gonzalez, Maria Angeles Villanueva-Eguaras, Manuel Ruben Sanchez-Crespo, Catherine Widmann, Frederic Brosseron, Ana Pozueta, Sara Lopez-Garcia, Maria Garcia-Martinez, Martha Kazimierczak, Maria Bravo-Gonzalez, Andrea Fernandez-Rodriguez, Marta Drake-Perez, Juan Irure-Ventura, Marcos Lopez-Hoyos, Eloy Rodriguez-Rodriguez, Michael T. Heneka, Pascual Sanchez-Juan
Summary: Surgery may accelerate memory decline in cognitively asymptomatic individuals with preclinical Alzheimer's disease, especially in those with abnormal levels of amyloid-beta, while the presence of amyloid-beta does not seem to impact the overall incidence of perioperative neurocognitive disorders.
JOURNAL OF ALZHEIMERS DISEASE
(2021)
Review
Neurosciences
Donovan A. McGrowder, Fabian Miller, Kurt Vaz, Chukwuemeka Nwokocha, Cameil Wilson-Clarke, Melisa Anderson-Cross, Jabari Brown, Lennox Anderson-Jackson, Lowen Williams, Lyndon Latore, Rory Thompson, Ruby Alexander-Lindo
Summary: This review presents the current evidence on CSF biomarkers for Alzheimer's disease, emphasizing the efficacy of existing core biomarkers and the need for further development of biomarkers reflecting other aspects of the disease mechanism. It also introduces new biomarkers that track Alzheimer's disease pathology and their potential in diagnosis and predicting cognitive decline.
Article
Medical Laboratory Technology
Rosa Ferrer, Nuole Zhu, Javier Arranz, Inmaculada Porcel, Shaimaa El Bounasri, Oriol Sanchez, Soraya Torres, Josep Julve, Alberto Lleo, Francisco Blanco-Vaca, Daniel Alcolea, Mireia Tondo
Summary: This study aimed to investigate the potential influence of different storage conditions on the quantification of biomarkers related to Alzheimer's disease in cerebrospinal fluid. The results showed that temperature and storage days significantly impacted the concentrations of certain biomarkers. However, the use of a ratio between two biomarkers could partially compensate for this influence. Other biomarkers were not affected by the tested storage conditions. The findings suggest that specific correction factors can be applied for samples stored at 4 degrees C.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
(2022)
Article
Clinical Neurology
Maya Arvidsson Radestig, Ingmar Skoog, Tobias Skillback, Henrik Zetterberg, Jurgen Kern, Anna Zettergren, Ulf Andreasson, Hanna Wetterberg, Silke Kern, Kaj Blennow
Summary: CSF NfL and Ng concentrations are increased in cognitively normal older adults with biomarker evidence of tau pathology and neurodegeneration.
ALZHEIMERS RESEARCH & THERAPY
(2023)
Article
Clinical Neurology
Lei Liu, Bianca M. Lauro, Amy He, Hyo Lee, Sanjay Bhattarai, Michael S. Wolfe, David A. Bennett, Celeste M. Karch, Tracy Young-Pearse, Dennis J. Selkoe
Summary: This study aims to identify biomarkers for Alzheimer's disease (AD) and finds that the A beta 37/42 ratio can be used to distinguish AD from normal aging. Experimental results show that this ratio outperforms the traditional ratio in differentiating physiological and pathological states in cell culture, brain tissue, and cerebrospinal fluid. The findings may provide a new indicator for early diagnosis of AD.
ALZHEIMERS & DEMENTIA
(2023)
Article
Neurosciences
Feifei Ge, Lin Dong, Donglin Zhu, Xingjian Lin, Jingping Shi, Ming Xiao
Summary: Thyroid dysfunction has been implicated in the pathogenesis of Alzheimer's disease (AD). This study found that even in euthyroid subjects, low levels of serum FT3 and TT3 are differentially associated with AD-specific CSF changes. Serum FT3 is a strong candidate for the differential diagnosis between AD continuum and non-AD dementia, benefiting the early diagnosis and effective management of AD patients.
JOURNAL OF ALZHEIMERS DISEASE
(2022)
Article
Biochemistry & Molecular Biology
Stefanos N. Sampatakakis, Eirini Mamalaki, Eva Ntanasi, Faidra Kalligerou, Ioannis Liampas, Mary Yannakoulia, Antonios N. Gargalionis, Nikolaos Scarmeas
Summary: Cognitive and physical decline in aging individuals seem to be associated. This study investigated the relationship between physical function parameters and CSF biomarkers in individuals in the AD continuum. The findings suggest an inverse association between walking time and CSF A beta 42, particularly in individuals with MCI and those older than 60 years old.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Clinical Neurology
Yuetiva Deming, Eva Vasiljevic, Autumn Morrow, Jiacheng Miao, Carol Van Hulle, Erin Jonaitis, Yue Ma, Vanessa Whitenack, Gwendlyn Kollmorgen, Norbert Wild, Ivonne Suridjan, Leslie M. Shaw, Sanjay Asthana, Cynthia M. Carlsson, Sterling C. Johnson, Henrik Zetterberg, Kaj Blennow, Barbara B. Bendlin, Qiongshi Lu, Corinne D. Engelman
Summary: APOE epsilon 4-carrier status and epsilon 4 allele count are not sufficient to fully account for the effects of APOE on Alzheimer's disease. A weighted risk score (APOE-npscore) was developed to better explain the genetic effect on neuropathology and provide an improved method for analyzing APOE in relation to AD. This approach outperformed the traditional APOE epsilon 4-carrier status and epsilon 4 allele count in predicting CSF biomarker changes.
ALZHEIMERS & DEMENTIA
(2023)
Article
Immunology
Kaja Nordengen, Bjorn-Eivind Kirsebom, Grit Richter, Lene Palhaugen, Berglind Gisladottir, Nikias Siafarikas, Arne Nakling, Arvid Rongve, Geir Brathen, Goril Rolfseng Grontvedt, Fernando Gonzalez, Knut Waterloo, Kulbhushan Sharma, Thomas Karikari, Eleonora M. Vromen, Betty M. Tijms, Pieter J. Visser, Per Selnes, Milicia G. Kramberger, Bengt Winblad, Kaj Blennow, Tormod Fladby
Summary: Brain innate immune activation is associated with Alzheimer's disease, with varying degrees of activation at different disease stages. In predementia AD, differences in immune activation levels and biomarker profiles may be related to amyloidosis and tau pathology. Changes in certain biomarkers in cerebrospinal fluid may be linked to cognitive preservation or impairment in predementia AD.
JOURNAL OF NEUROINFLAMMATION
(2023)
Article
Clinical Neurology
Anna M. De Kort, H. Bea Kuiperij, Daniel Alcolea, Iris Kersten, Alexandra A. M. Versleijen, Steven M. Greenberg, Erik Stoops, Floris H. B. M. Schreuder, Catharina J. M. Klijn, Alberto Lleo, Jurgen A. H. R. Claassen, Marcel M. Verbeek
Summary: Our study found that CSF NLK levels are elevated in aMCI and AD patients compared to controls, but did not increase in CAA patients. Furthermore, we observed a correlation of CSF NLK with CSF YKL-40 in aMCI/AD patients.
ALZHEIMERS RESEARCH & THERAPY
(2021)
Article
Neurosciences
Marcos Pais, Julia Loureiro, Vagner do Vale, Marcia Radanovic, Leda Talib, Florindo Stella, Orestes Forlenza
Summary: Analysis of CSF biomarkers was able to differentiate between AD, MCI, and NC, yet clinical-biological mismatches were observed in a non-negligible proportion of cases.
JOURNAL OF ALZHEIMERS DISEASE
(2021)
Article
Oncology
Jessica C. Gooch, Freya Schnabel, Jennifer Chun, Elizabeth Pirraglia, Andrea B. Troxel, Amber Guth, Richard Shapiro, Deborah Axelrod, Daniel Roses
ANNALS OF SURGICAL ONCOLOGY
(2019)
Article
Clinical Neurology
Mia T. Minen, Gabriella Sahyoun, Ariana Gopal, Valeriya Levitan, Elizabeth Pirraglia, Naomi M. Simon, Audrey Halpern
Review
Dentistry, Oral Surgery & Medicine
Angela R. Kamer, Ronald G. Craig, Richard Niederman, Juan Fortea, Mony J. de Leon
PERIODONTOLOGY 2000
(2020)
Review
Clinical Neurology
Omonigho M. Bubu, Andreia G. Andrade, Ogie Q. Umasabor-Bubu, Megan M. Hogan, Arlener D. Turner, Mony J. de Leon, Gbenga Ogedegbe, Indu Ayappa, Girardin Jean-Louis, Melinda L. Jackson, Andrew W. Varga, Ricardo S. Osorio
SLEEP MEDICINE REVIEWS
(2020)
Article
Clinical Neurology
Aneela Rahman, Eva Schelbaum, Katherine Hoffman, Ivan Diaz, Hollie Hristov, Randolph Andrews, Steven Jett, Hande Jackson, Andrea Lee, Harini Sarva, Silky Pahlajani, Dawn Matthews, Jonathan Dyke, Mony J. de Leon, Richard S. Isaacson, Roberta D. Brinton, Lisa Mosconi
Article
Clinical Neurology
Omonigho M. Bubu, Ogie Q. Umasabor-Bubu, Arlener D. Turner, Ankit Parekh, Anna E. Mullins, Korey Kam, Madeline K. Birckbichler, Fahad Mukhtar, Alfred K. Mbah, Natasha J. Williams, David M. Rapoport, Mony de Leon, Girardin Jean-Louis, Indu Ayappa, Andrew W. Varga, Ricardo S. Osorio
Summary: This study found that regardless of TN-status, participants with OSA+/Aβ+ were 2 to 4 times more likely to progress to MCI/AD and progress 6 to 18 months earlier compared to other participants. The study also demonstrated synergistic effects between OSA and Aβ, as well as between OSA and tau, leading to shorter progression time to MCI/AD in CN and MCI-OSA patients when Aβ and tau accumulation becomes increasingly abnormal.
ALZHEIMERS & DEMENTIA
(2021)
Article
Clinical Neurology
Jerzy Wegiel, Michael Flory, Izabela Kuchna, Krzysztof Nowicki, Shuang Yong Ma, Jarek Wegiel, Eulalia Badmaev, Mony de Leon, Thomas Wisniewski, Barry Reisberg
Summary: This study aims to establish the pattern of neurodegeneration and the severity and rate of neuronal loss in Alzheimer's disease patients at different stages. It found that the severity of neuronal loss was most significant in early stages, while the rate of loss peaked at moderate to moderately severe stages before declining in severe stages. This suggests that intervening to prevent neuronal loss may help halt disease progression.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
(2021)
Article
Clinical Neurology
Simona I. Hategan, Sabrina A. Kamer, Ronald G. Craig, Cosmin Sinescu, Mony J. de Leon, Dragos C. Jianu, Catalin Marian, Bianca I. Bora, Traian-Flavius Dan, Claudiu D. Birdac, Anca Marcu, Angela R. Kamer, Meda Lavinia Negrutiu
Summary: The study revealed that young healthy individuals with periodontal disease may have lower cognition, and salivary IL-1 beta may play a role in this process, showing cognitive dysfunction in subjects with aggressive periodontitis for the first time.
NEUROLOGICAL SCIENCES
(2021)
Article
Endocrinology & Metabolism
Heather T. Gold, Elizabeth Pirraglia, Elbert S. Huang, Wen Wan, Andrea B. Pascual, Ryan James Jensen, Andrea Gerard Gonzalez
Summary: The study evaluated the costs and healthcare utilization of a culturally-sensitive medical and education program for pediatric Latino patients with type 1 diabetes. The program successfully reduced hospitalizations and emergency department visits, resulting in significant cost savings and improved healthcare utilization for the participants.
PEDIATRIC DIABETES
(2021)
Article
Multidisciplinary Sciences
Lisa Mosconi, Valentina Berti, Jonathan Dyke, Eva Schelbaum, Steven Jett, Lacey Loughlin, Grace Jang, Aneela Rahman, Hollie Hristov, Silky Pahlajani, Randolph Andrews, Dawn Matthews, Orli Etingin, Christine Ganzer, Mony de Leon, Richard Isaacson, Roberta Diaz Brinton
Summary: The neuroimaging study revealed significant differences in brain structure, connectivity, and energy metabolism across menopause transition stages in women, suggesting a dynamic neurological transition that significantly impacts brain function and cognition.
SCIENTIFIC REPORTS
(2021)
Article
Neurosciences
Yi Li, Henry Rusinek, Tracy Butler, Lidia Glodzik, Elizabeth Pirraglia, John Babich, P. David Mozley, Sadek Nehmeh, Silky Pahlajani, Xiuyuan Wang, Emily B. Tanzi, Liangdong Zhou, Sara Strauss, Roxana O. Carare, Neil Theise, Nobuyuki Okamura, Mony J. de Leon
Summary: This study found reduced CSF clearance in Alzheimer's disease, which is associated with brain amyloid-beta deposition and cognitive decline.
FLUIDS AND BARRIERS OF THE CNS
(2022)
Article
Neurosciences
Russell H. Swerdlow, Mony J. de Leon, David L. Marcus
Summary: The rate of BHB utilization in Alzheimer's disease brains is 66% lower compared to control brains, indicating possible mitochondrial dysfunction or altered mitochondrial biology in AD brains.
JOURNAL OF ALZHEIMERS DISEASE REPORTS
(2021)
Article
Clinical Neurology
Angela R. Kamer, Smruti Pushalkar, Deepthi Gulivindala, Tracy Butler, Yi Li, Kumar Raghava Chowdary Annam, Lidia Glodzik, Karla Ballman, Patricia M. Corby, Kaj Blennow, Henrik Zetterberg, Deepak Saxena, Mony J. de Leon
Summary: The study found an association between subgingival periodontal dysbiosis and CSF biomarkers of amyloidosis (Aβ), but not with P-tau. Further research is needed to establish a direct link between oral bacteria and amyloid beta.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING
(2021)
Article
Clinical Neurology
Roxana O. Carare, Roxana Aldea, Nivedita Agarwal, Brian J. Bacskai, Ingo Bechman, Delphine Boche, Guojun Bu, Diederik Bulters, Alt Clemens, Scott E. Counts, Mony de Leon, Per K. Eide, Silvia Fossati, Steven M. Greenberg, Edith Hamel, Cheryl A. Hawkes, Maya Koronyo-Hamaoui, Atticus H. Hainsworth, David Holtzman, Masafumi Ihara, Angela Jefferson, Raj N. Kalaria, Christopher M. Kipps, Katja M. Kanninen, Ville Leinonen, JoAnne McLaurin, Scott Miners, Tarja Malm, James A. R. Nicoll, Fabrizio Piazza, Gesine Paul, Steven M. Rich, Satoshi Saito, Andy Shih, Henrieta Scholtzova, Heather Snyder, Peter Snyder, Finnbogi Rutur Thormodsson, Susanne J. van Veluw, Roy O. Weller, David J. Werring, Donna Wilcock, Mark R. Wilson, Berislav Zlokovic, Ajay Verma
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING
(2020)
Article
Clinical Neurology
Silvia Fossati, Jaime Ramos Cejudo, Ludovic Debure, Elizabeth Pirraglia, Je Yeong Sone, Yi Li, Jingyun Chen, Tracy Butler, Henrik Zetterberg, Kaj Blennow, Mony J. de Leon
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING
(2019)
Review
Neurosciences
Maya Jammoul, Dareen Jammoul, Kevin K. Wang, Firas Kobeissy, Ralph G. Depalma
Summary: This article reviews the possible mechanisms by which traumatic brain injury (TBI) may stimulate the development of opioid use disorder (OUD) and discusses the interaction between these two processes. CNS damage due to TBI appears to drive adverse effects of subsequent OUD, with pain being a risk factor for opioid use after TBI.
BIOLOGICAL PSYCHIATRY
(2024)
Article
Neurosciences
Danusa Mar Arcego, Jan-Paul Buschdorf, Nicholas O'Toole, Zihan Wang, Barbara Barth, Irina Pokhvisneva, Nirmala Arul Rayan, Sachin Patel, Euclides Jose de Mendonca Filho, Patrick Lee, Jennifer Tan, Ming Xuan Koh, Chu Ming Sim, Carine Parent, Randriely Merscher Sobreira de Lima, Andrew Clappison, Kieran J. O'Donnell, Carla Dalmaz, Janine Arloth, Nadine Provencal, Elisabeth B. Binder, Josie Diorio, Patricia Pelufo Silveira, Michael J. Meaney
Summary: This study investigates the impact of environmental influences on mental health by integrating transcriptomic data from animal models with human data. The results suggest that hippocampal glucocorticoid-related transcriptional activity mediates the effects of early adversity on neural mechanisms implicated in psychiatric disorders.
BIOLOGICAL PSYCHIATRY
(2024)
Article
Neurosciences
Milenna T. van Dijk, Ardesheer Talati, Pratik Kashyap, Karan Desai, Nora C. Kelsall, Marc J. Gameroff, Natalie Aw, Eyal Abraham, Breda Cullen, Jiook Cha, Christoph Anacker, Myrna M. Weissman, Jonathan Posner
Summary: This study found that maternal stress is associated with future depressive symptoms and alterations in microstructure of the dentate gyrus (DG) in offspring. These results were consistent across two independent cohorts.
BIOLOGICAL PSYCHIATRY
(2024)
Article
Neurosciences
Josephine C. McGowan, Liliana R. Ladner, Claire X. Shubeck, Juliana Tapia, Christina T. LaGamma, Amanda Anqueira-Gonzalez, Ariana DeFrancesco, Briana K. Chen, Holly C. Hunsberger, Ezra J. Sydnor, Ryan W. Logan, Tzong-Shiue Yu, Steven G. Kernie, Christine A. Denny
Summary: Traumatic brain injury (TBI) leads to fear generalization by altering fear memory traces, and this symptom can be improved with (R,S)-ketamine.
BIOLOGICAL PSYCHIATRY
(2024)